IMVT
Price
$22.86
Change
+$0.11 (+0.48%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
3.36B
29 days until earnings call
SLNO
Price
$42.51
Change
-$0.55 (-1.28%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
1.83B
70 days until earnings call
Ad is loading...

IMVT vs SLNO

Header iconIMVT vs SLNO Comparison
Open Charts IMVT vs SLNOBanner chart's image
Immunovant
Price$22.86
Change+$0.11 (+0.48%)
Volume$62.31K
Capitalization3.36B
Soleno Therapeutics
Price$42.51
Change-$0.55 (-1.28%)
Volume$6.49K
Capitalization1.83B
IMVT vs SLNO Comparison Chart
Loading...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMVT vs. SLNO commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Buy and SLNO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (IMVT: $22.75 vs. SLNO: $43.06)
Brand notoriety: IMVT and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 139% vs. SLNO: 58%
Market capitalization -- IMVT: $3.34B vs. SLNO: $1.86B
IMVT [@Biotechnology] is valued at $3.34B. SLNO’s [@Biotechnology] market capitalization is $1.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $385.53B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMVT and SLNO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 4 TA indicator(s) are bullish while SLNO’s TA Score has 3 bullish TA indicator(s).

  • IMVT’s TA Score: 4 bullish, 2 bearish.
  • SLNO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than SLNO.

Price Growth

IMVT (@Biotechnology) experienced а -7.63% price change this week, while SLNO (@Biotechnology) price change was -6.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.05%. For the same industry, the average monthly price growth was -1.49%, and the average quarterly price growth was -2.91%.

Reported Earning Dates

IMVT is expected to report earnings on May 28, 2025.

SLNO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-7.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($3.36B) has a higher market cap than SLNO($1.83B). SLNO YTD gains are higher at: -4.205 vs. IMVT (-8.155). SLNO has higher annual earnings (EBITDA): -136.5M vs. IMVT (-352.16M). IMVT has more cash in the bank: 473M vs. SLNO (257M). IMVT has less debt than SLNO: IMVT (47K) vs SLNO (3.03M). IMVT (0) and SLNO (0) have equivalent revenues.
IMVTSLNOIMVT / SLNO
Capitalization3.36B1.83B183%
EBITDA-352.16M-136.5M258%
Gain YTD-8.155-4.205194%
P/E RatioN/AN/A-
Revenue00-
Total Cash473M257M184%
Total Debt47K3.03M2%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMVTSLNO
RSI
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 7 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
80%
Bearish Trend 7 days ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 7 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 7 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 7 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 12 days ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
82%
Bearish Trend 22 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
84%
N/A
Aroon
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSVSX15.260.15
+0.99%
Janus Henderson Small-Mid Cap Value S
VVIPX14.45N/A
N/A
Voya VACS Index S
CNPCX57.27-0.11
-0.19%
American Funds New Perspective 529C
LIRTX7.77-0.03
-0.38%
Lord Abbett International Value R5
FAUFX43.05-0.61
-1.40%
Fidelity Advisor Utilities M

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
-3.11%
ROIV - IMVT
50%
Loosely correlated
+1.03%
BRNS - IMVT
48%
Loosely correlated
-8.74%
KYMR - IMVT
41%
Loosely correlated
-2.49%
SNDX - IMVT
38%
Loosely correlated
-2.36%
GRCE - IMVT
38%
Loosely correlated
-6.68%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
-0.12%
BRNS - SLNO
56%
Loosely correlated
-8.74%
KANT - SLNO
45%
Loosely correlated
+2.38%
XENE - SLNO
42%
Loosely correlated
-0.42%
KYMR - SLNO
40%
Loosely correlated
-2.49%
ACLX - SLNO
40%
Loosely correlated
-2.49%
More